U.S. study finds AstraZeneca vaccine 79% effective against symptomatic COVID-19

U.S. study finds AstraZeneca vaccine 79% effective against symptomatic COVID-19

Drugmaker AstraZeneca is preparing to request emergency use authorization for its coronavirus vaccine in the U.S. after its latest clinical trial finds the vaccine was fully effective in preventing COVID-19 hospitalizations and 79% effective in stopping symptomatic illness. Dr. Alonzo Plough, chief science officer at the Robert Wood Johnson Foundation, joins CBSN to discuss the potential impact in the fight against the pandemic.

CBSN is CBS News’ 24/7 digital streaming news service featuring live, anchored coverage available for free across all platforms. Launched in November 2014, the service is a premier destination for breaking news and original storytelling from the deep bench of CBS News correspondents and reporters. CBSN features the top stories of the day as well as deep dives into key issues facing the nation and the world. CBSN has also expanded to launch local news streaming services in major markets across the country. CBSN is currently available on CBSNews.com and the CBS News app across more than 20 platforms, as well as the Paramount+ subscription service.

Subscribe to the CBS News YouTube channel: http://youtube.com/cbsnews​
Watch CBSN live: http://cbsn.ws/1PlLpZ7c​
Download the CBS News app: http://cbsn.ws/1Xb1WC8​
Follow CBS News on Instagram: https://www.instagram.com/cbsnews/​
Like CBS News on Facebook: http://facebook.com/cbsnews​
Follow CBS News on Twitter: http://twitter.com/cbsnews​
Subscribe to our newsletters: http://cbsn.ws/1RqHw7T​
Try Paramount+ free: https://bit.ly/2OiW1kZ

For licensing inquiries, contact: licensing@veritone.com

More News Stories

Loading...

More Political News

Loading...